(+-)-LORAZEPAM--DEA SCHEDULE IV ITEM

Biochem/physiol Actions

Anxiolytic; ligand for the GABA_A receptor benzodiazepine modulatory site.

Features and Benefits

This compound was developed by Baxter. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Molecular Weight: 321.16. Empirical Formula: C₁₅H₁₀Cl₂N₂O₂. Quality Level: 200. drug control: USDEA Schedule IV. Home Office Schedule 4.1. psychotrope (France). kontrollierte Droge in Deutschland. regulated under CDSA - not available from Sigma-Aldrich Canada. psicótropo (Spain). Decreto Lei 15/93: Tabela IV (Portugal). originator: Baxter. SMILES string: OC1N: C(c2ccccc2Cl)c3cc(Cl)ccc3NC1: O. InChI: 1S/C15H10Cl2N2O2/c16-8-5-6-12-10(7-8)13(19-15(21)14(20)18-12)9-3-1-2-4-11(9)17/h1-7,15,21H,(H,18,20). InChI key: DIWRORZWFLOCLC-UHFFFAOYSA-N. Gene Information: human ... GABRA1(2554), GABRA2(2555), GABRA3(2556), GABRA4(2557), GABRA5(2558), GABRA6(2559), GABRB1(2560), GABRB2(2561), GABRB3(2562), GABRD(2563), GABRE(2564), GABRG1(2565), GABRG2(2566), GABRG3(2567), GABRP(2568), GABRQ(55879). Pictograms: GHS08. Signal Word: Warning. Hazard Statements: H361d. Precautionary Statements: P201 - P202 - P280 - P308 + P313 - P405 - P501. Hazard Classifications: Repr. 2. Storage Class Code: 11 - Combustible Solids. WGK: WGK 3. Flash Point(F): Not applicable. Flash Point(C): Not applicable. Personal Protective Equipment: Eyeshields, Gloves, type P3 (EN 143) respirator cartridges.